LobbyingMayne Pharma lobbying by quarter
Mayne Pharma's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $220K. Its first report covers Q2 2025; the issues it reports most are Health Issues.
Mayne Pharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $220K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $70K | 1 |
| Q3 2025 | $70K | 1 |
| Q4 2025 | $70K | 1 |
| Q1 2026 | $70K | 2 |
| Q2 2026 | $80K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$290K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES6 reports
- SENATE6 reports
- Executive Office of the President (EOP)2 reports
- Health & Human Services, Dept of (HHS)2 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Akin Gump Strauss Hauer & Feld | $350K | 5 quarters |
| G2G Consulting | $10K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHRISTOPHER WILLIAM COOPER | Chief Appropriations Counsel,Chief of Staff,Legislative Director,Senior Legislative Assistant,Legislative Assistant for David Joyce (2013-2023) & Legislative Assistant/ Correspondent,Staff Assistant,Legislative Intern for Steven LaTourette(2011-2013) | Q2 2026 |
| ELIZABETH POWELL | Legislative Director for Rep. Jim Langevin 2001-2002 and Legislative Director for Rep. Juanita Millender-McDonald 1997-2001 | Q2 2026 |
| KATHERINE M COLLINS | Deputy Director of Operations, The Executive Residence, Executive Office of the President (2011-2016) and Policy Associate, White House Cancer Moonshot Task Force, Office of the Vice President, Executive Office of the President (2016-2017) | Q2 2026 |
| MIA HECK | Confidential Asst. to Asst. Sec Pub. Affairs, ASPA, HHS (9/02 - 3/04) Dir. Special Proj., IOS, HHS (1/05 - 2/06) Snr Adv. to Administrator, CMS, HHS (10/17 - 1/18) Snr Adv., IEA, HHS (1/18 - 6/19) Dir. External Affairs, OASH, HSS (6/19-1/21) | Q1 2026 |
| ILEANA ROS-LEHTINEN | Mbr of Cong. 1989-2019 | Q3 2025 |
| ZACH DEATHERAGE | Sr. Leg. Asst. & Leg. Dir., Rep. Stefanik (2/23-1/25); Leg. Asst., Rep. Hinson (1/21-2/23); Leg. Cor., Leg. Aide, & Leg. Asst., Rep. Ralph Abraham (6/19-1/21); Intern & Staff Asst., Rep. Steve Womack (6/18-6/19); Intern, Sen. Joni Ernst (7/16-8/16). | Q3 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | G2G Consulting | $10K |
| 07/20for Q2 | Akin Gump Strauss Hauer & Feld | $70K |
| 04/21for Q1 | G2G Consulting | Under $5,000 |
| 04/20for Q1 | G2G Consulting | Under $5,000 |
| 04/20for Q1 | Akin Gump Strauss Hauer & Feld | $70K |
| 01/20for Q4 2025 | Akin Gump Strauss Hauer & Feld | $70K |
| 25/10/20for Q3 2025 | Akin Gump Strauss Hauer & Feld | $70K |
| 25/07/21for Q2 2025 | Akin Gump Strauss Hauer & Feld | $70K |
| 25/07/14for Q2 2025 | Akin Gump Strauss Hauer & Feld | Under $5,000 |